Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2021 Nov 15;9(11):e002968corr1. doi: 10.1136/jitc-2021-002968corr1

Correction: Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML

PMCID: PMC8593719  PMID: 34782434

Herbrich S, Baran N, Cai T, et al. Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML. J Immunother Cancer 2021;9:e002968. doi:10.1136/jitc-2021-002968

This article has been corrected since it was first published. Ondrej Havranek has now been added as an author.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES